Preliminary Assessment of an Automated Tool for Diabetic Retinopathy Screening
ConditionDiabetic Retinopathy (DR)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorCentervue SpA
About this trial
This study is being done to evaluate the performance of a software that uses artificial intelligence to analyze photographs of the retina to help detect diabetic retinopathy. The study will also assess the safety of the software in combination with a fundus camera already available on the market. This software analyzes retinal photographs to detect more than mild diabetic retinopathy in adults with diabetes. The results will be compared to expert human evaluations.
Eligibility criteria
Qualifiers
22 years old or older
diabetes or diabetic retinopathy
understand the study information and able to sign a consent form
Disqualifiers
cannot tolerate eye imaging tests
laser treatment or injections
eye surgery, except for simple cataract surgery
currently involved in another study
Trial design
Treatments tested in this trial
- automatic analysis of fundus images performed by the software tool based on artificial intelligence
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov